Total Valuation
TATA Health International Holdings Ltd. has a market cap or net worth of HK$509.97M. The enterprise value is HK$323.64.
Market CapHK$509.97M
Enterprise ValueHK$323.64
Share Statistics
TATA Health International Holdings Ltd. has 242,845,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding242,845,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
TATA Health International Holdings Ltd.’s return on equity (ROE) is -0.25 and return on invested capital (ROIC) is 80.15%.
Return on Equity (ROE)-0.25
Return on Assets (ROA)0.15
Return on Invested Capital (ROIC)80.15%
Return on Capital Employed (ROCE)0.46
Revenue Per Employee1.01M
Profits Per Employee134.85K
Employee Count99
Asset Turnover1.10
Inventory Turnover2.05
Valuation Ratios
The current PE Ratio of TATA Health International Holdings Ltd. is 38.2. TATA Health International Holdings Ltd.’s PEG ratio is -0.20.
PE Ratio38.2
PS Ratio3.16
PB Ratio-5.80
Price to Fair Value-5.80
Price to FCF-14.09
Price to Operating Cash Flow-27.43
PEG Ratio-0.20
Income Statement
In the last 12 months, TATA Health International Holdings Ltd. had revenue of 99.80M and earned 13.35M in profits. Earnings per share was 0.06.
Revenue99.80M
Gross Profit80.26M
Operating Income-23.19M
Pretax Income13.99M
Net Income13.35M
EBITDA-20.55M
Earnings Per Share (EPS)0.06
Cash Flow
In the last 12 months, operating cash flow was -18.59M and capital expenditures -3.81M, giving a free cash flow of -22.40M billion.
Operating Cash Flow-18.59M
Free Cash Flow-22.40M
Free Cash Flow per Share-0.09
Dividends & Yields
TATA Health International Holdings Ltd. pays an annual dividend of HK$0.023, resulting in a dividend yield of ―
Dividend Per ShareHK$0.023
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.11
52-Week Price Change600.00%
50-Day Moving Average2.68
200-Day Moving Average1.82
Relative Strength Index (RSI)35.33
Average Volume (3m)0.00
Important Dates
TATA Health International Holdings Ltd. upcoming earnings date is Aug 28, 2026, TBA (Confirmed).
Last Earnings DateMar 31, 2026
Next Earnings DateAug 28, 2026
Ex-Dividend Date―
Financial Position
TATA Health International Holdings Ltd. as a current ratio of 0.50, with Debt / Equity ratio of -47.52%
Current Ratio0.50
Quick Ratio0.43
Debt to Market Cap0.03
Net Debt to EBITDA-0.39
Interest Coverage Ratio-8.29
Taxes
In the past 12 months, TATA Health International Holdings Ltd. has paid 637.00K in taxes.
Income Tax637.00K
Effective Tax Rate0.05
Enterprise Valuation
TATA Health International Holdings Ltd. EV to EBITDA ratio is -15.75, with an EV/FCF ratio of -14.45.
EV to Sales3.24
EV to EBITDA-15.75
EV to Free Cash Flow-14.45
EV to Operating Cash Flow-17.41
Balance Sheet
TATA Health International Holdings Ltd. has HK$17.92M in cash and marketable securities with HK$25.87M in debt, giving a net cash position of -HK$7.95M billion.
Cash & Marketable SecuritiesHK$17.92M
Total DebtHK$25.87M
Net Cash-HK$7.95M
Net Cash Per Share-HK$0.03
Tangible Book Value Per Share-HK$0.22
Margins
Gross margin is 80.43%, with operating margin of -23.24%, and net profit margin of 13.38%.
Gross Margin80.43%
Operating Margin-23.24%
Pretax Margin14.02%
Net Profit Margin13.38%
EBITDA Margin-20.59%
EBIT Margin-23.24%
Analyst Forecast
The average price target for TATA Health International Holdings Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-19.81%
EPS Growth Forecast―